Skip to main content
. 2020 Dec 9;190(7):1210–1219. doi: 10.1093/aje/kwaa260

Figure 2.

Figure 2

Probability of remaining free of a severe depression-related outcome, stratified by selective serotonin reuptake inhibitor, Clinical Practice Research Datalink, United Kingdom, 1998–2017. The cross-dotted lines are the crude Kaplan-Meier estimates, and the full curves are adjusted for confounder variables at baseline via an inverse probability of treatment weight (fluoxetine users, black; citalopram users, gray).